Quickly supply alternative strategic theme areas vis-a-vis B2C mindshare. Objectively repurpose stand-alone synergy via user-centric architectures.

FOLLOW US ON:

Recent Posts

Get in touch!

Fusce varius, dolor tempor interdum tristiquei bibendum service life.

147/I, Green Road, Gulshan Avenue, Panthapath, Dhaka

[email protected]
+256 214 203 215
+1 (905) 427-9237 [email protected] 602-350 Burnhamthorpe Road West, Mississauga, ON
Contact Us

Industry News

Photo Credit: The New York Times

Working From Home Is Harming Young Employees. They’re Starting to See That.

Remote work means less training and opportunity for advancement, especially for younger workers, research suggests. Some are getting the message.
Read more →
Eli Lilly Logo
Antranik Tavitian/Reuters

Eli Lilly Reaches $1 Trillion in Value, Buoyed by Demand for Its Weight Loss Drugs

The booming market for weight-loss drugs has propelled Eli Lilly to become the first pharmaceutical company to hit $1 trillion, joining a select club of mostly tech companies that have surpassed that threshold.
Read more →
Photo Credit: Google Maps

$500M Cambridge Biotech Research Hub Abruptly Closes

Arena BioWorks was supposed to be a breath of fresh air for the Greater Boston life sciences market, but its bright bulb just went out.
Read more →
The Globe and Mail (Ontario Edition)Peter Singer

Overcoming Canada’s innovation barrier will lead to more productivity

The latest federal budget includes $1.7-billion for attracting international talent, a welcome investment in a country where we struggle to turn scientific discoveries into innovations that drive economic growth.
Read more →
The Globe and Mail (Ontario Edition) Joe Friesen

Universities could jump to hire foreign researchers if Ottawa allocates funds

Universities have been waiting to see what direction the federal government will take as other countries have jumped on the potential hiring opportunity created by recent instability in U.S. academic funding.
Read more →
The Globe and Mail Chris Hannay

Vimy Pharma: Company says product won’t be available in January, still aiming for 2026

As the race among drug makers heats up to deliver a generic form of the blockbuster drug Ozempic next year, Vimy Pharmaceuticals Inc., a new entrant to the field, is aiming to produce a made-inCanada version.
Read more →
The Globe and Mail (Ontario Edition) Alanna Smith

With measles elimination status in peril, country faces a wake-up call

Canadian health experts equipped with binders of information on the prolonged measles outbreak will travel in November to Mexico City, where an international committee will determine whether Canada maintains its elimination status for the disease.
Read more →
WSJ: Harun Ozalp/Anadolu/Getty Images

Why Biotech’s Rally Can Last This Time

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another short-lived bounce.
Read more →
Photo: CBC Steven Senne/The Associated Press)

Why ‘organ chips’ could transform cancer treatment and drug testing

Lab-made technology with living tissue could guide future drug development, scientists say.
Read more →